Guideline amendment provides updated insights on imaging, treatment, and decision-making in prostate cancer, implying ongoing improvements.
This Amendment provides several new insights, including revised guidance on imaging, updated information on shared decision-making (SDM), and new direction regarding radiation treatment and disease management. This Guideline will require further review as the diagnostic and treatment options in this space continue to evolve.
No takes yet. Share an insight, caveat, or question.
Eastham et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: